Tesamorelin 10 mg — Lyophilized Vial 10 mg · 1 vial

What is Tesamorelin?

Tesamorelin is a synthetic analog of growth-hormone-releasing hormone, or GHRH. It stimulates the pituitary growth-hormone axis rather than supplying growth hormone directly.

Biological activity

By acting through the GHRH pathway, tesamorelin can increase growth-hormone secretion and downstream IGF-1 signaling. Research examines how that endocrine response relates to changes in visceral adipose tissue, the fat located around abdominal organs.

Purpose and areas of study

It has been studied in randomized human trials involving abdominal fat accumulation in people with HIV. Those studies evaluated visceral fat and related metabolic measures. The purpose is more specific than general weight loss: researchers distinguish visceral fat from subcutaneous fat beneath the skin.

Evidence context

Clinical findings concern specific formulations and participant populations. They should not be generalized to universal weight-loss benefits or to this vial.

Product presentation

One lyophilized vial. Labeled content: 10 mg.

Scientific references

PubMed 20101189; PubMed 25038357

Research-use information

All information on this page is provided for scientific education and research purposes only. This product is intended exclusively for laboratory research and is not for human or veterinary use. The information is not medical advice or a claim of therapeutic benefit.